Insider Selling: Furiex Pharmaceuticals VP Sells 30,000 Shares of Stock (FURX)
Furiex Pharmaceuticals (NASDAQ:FURX) VP Paul Covington sold 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $40.89, for a total transaction of $1,226,700.00. Following the sale, the vice president now directly owns 15,123 shares of the company’s stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Separately, analysts at Canaccord Genuity raised their price target on shares of Furiex Pharmaceuticals (NASDAQ:FURX) from $47.00 to $51.00 in a research note to investors on Wednesday, August 7th.
Shares of Furiex Pharmaceuticals (NASDAQ:FURX) traded up 0.72% on Thursday, hitting $42.15. The stock had a trading volume of 22,778 shares. Furiex Pharmaceuticals has a 52 week low of $17.50 and a 52 week high of $49.50. The stock has a 50-day moving average of $41.62 and a 200-day moving average of $37.77. The company’s market cap is $434.0 million.
Furiex Pharmaceuticals (NASDAQ:FURX) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($2.32) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($1.65) by $0.67. The company had revenue of $3.00 million for the quarter, compared to the consensus estimate of $11.94 million. The company’s quarterly revenue was down 77.1% on a year-over-year basis. On average, analysts predict that Furiex Pharmaceuticals will post $-3.34 earnings per share for the current fiscal year.
Furiex Pharmaceuticals, Inc is a drug development collaboration company. The Company’s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.